Erratum: Homogentisate 1-2-dioxygenase downregulation in the chronic persistence of pseudomonas aeruginosa australian epidemic strain-1 in the CF Lung (PLoS ONE (2015) 10:8 (e0134229) DOI 10.1371/journal.pone.0134229);Homogentisate 1-2-dioxygenase downregulation in the chronic persistence of pseudomonas aeruginosa Australian epidemic strain-1 in the CF lung

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Harmer, Christopher J ^a   Wynn, Matthew ^a   Pinto, Rachel ^a   Cordwell, Stuart ^a   Rose, Barbara R ^a   Harbour, Colin ^a   Triccas, James A ^a   Manos, Jim ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP A PROTEIN; HOMOGENTISATE 1,2 DIOXYGENASE; TUMOR NECROSIS FACTOR ALPHA; BACTERIAL PROTEIN; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DOWN REGULATION; ENZYME INACTIVATION; ENZYME REGULATION; FEMALE; GENE FUNCTION; GENOTYPE PHENOTYPE CORRELATION; HMGA GENE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; UPREGULATION; ANIMAL; AUSTRALIA; C57BL MOUSE; CAENORHABDITIS ELEGANS; DISEASE MODEL; DNA MICROARRAY; DRUG EFFECTS; ENZYMOLOGY; EPIDEMIC; FLOW CYTOMETRY; GENOTYPE; IMMUNOPHENOTYPING; LUNG; METABOLISM; MICROBIOLOGY; MUTATION; PATHOGENICITY; PATHOLOGY; PHENOTYPE; PSEUDOMONAS INFECTION; VIRULENCE;

ANIMALS; AUSTRALIA; BACTERIAL PROTEINS; CAENORHABDITIS ELEGANS; CYSTIC FIBROSIS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EPIDEMICS; FEMALE; FLOW CYTOMETRY; GENOTYPE; HOMOGENTISATE 1,2-DIOXYGENASE; IMMUNOPHENOTYPING; LUNG; MICE, INBRED C57BL; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE;

EID: 84941985550     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138633     Document Type: Erratum

References (30)

1. Kenna DT, Doherty CJ, Foweraker J, Macaskill L, Barcus VA, Govan JR. Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis. Microbiology. 2007; 153(Pt 6):1852-9. PMID: 17526842.
2. Yates SP, Merrill AR. Elucidation of eukaryotic elongation factor-2 contact sites within the catalytic domain of Pseudomonas aeruginosa exotoxin A. Biochem J. 2004; 379(Pt 3):563-72. PMID: 14733615.
3. Waite RD, Papakonstantinopoulou A, Littler E, Curtis MA. Transcriptome analysis of Pseudomonas aeruginosa growth: comparison of gene expression in planktonic cultures and developing and mature biofilms. J Bacteriol. 2005; 187(18):6571-6. PMID: 16159792.
4. Hoboth C, Hoffmann R, Eichner A, Henke C, Schmoldt S, Imhof A, et al. Dynamics of Adaptive Microevolution of Hypermutable Pseudomonas aeruginosa during Chronic Pulmonary Infection in Patients with Cystic Fibrosis. Journal of Infectious Diseases. 2009; 200(1):118-30. doi: 10.1086/599360 PMID: ISI:000266516700018.
5. Armstrong D, Bell S, Robinson M, Bye P, Rose B, Harbour C, et al. Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics. J Clin Microbiol. 2003; 41(5):2266-7. PMID: 12734299.
6. Griffiths AL, Wurzel DF, Robinson PJ, Carzino R, Massie J. Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic. J Cyst Fibros. 2012; 11(1):49-52. PMID: 21907639. doi: 10.1016/j.jcf.2011.08.005
7. Harmer C, Alnassafi K, Hu H, Elkins M, Bye P, Rose B, et al. Modulation of gene expression by P. aeruginosa during chronic infection in the adult cystic fibrosis lung. Microbiology. 2013; 159(Pt 11):2354-63. PMID: 24014664.
8. Manos J, Arthur J, Rose B, Tingpej P, Fung C, Curtis M, et al. Transcriptome analyses and biofilm-forming characteristics of a clonal P. aeruginosa from the cystic fibrosis lung. J Med Microbiol. 2008; 57(Pt 12):1454-65. Epub 2008/11/20. 57/12/1454 [pii] doi: 10.1099/jmm.0.2008/005009-0 PMID: 19018014.
9. Naughton S, Parker D, Seemann T, Thomas T, Turnbull L, Rose B, et al. P. aeruginosa AES-1 exhibits increased virulence gene expression during chronic infection of cystic fibrosis lung. PLoS One. 2011; 6 (9):e24526. PMID: 21935417. doi: 10.1371/journal.pone.0024526
10. Fung C, Naughton S, Turnbull L, Tingpej P, Rose B, Arthur J, et al. Gene expression of P. aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum. J Med Microbiol. 2010; 59(Pt 9):1089-100. Epub 2010/06/05. jmm.0.019984-0 [pii] doi: 10.1099/jmm.0.019984-0 PMID: 20522626.
11. Imlay JA, Hassett DJ. Oxidative stress and nitrosative stress defence systems in Escherichia coli and Pseudomonas aeruginosa: A model organism of study versus a human opportunistic pathogen. Kidd SP, editor. Reading CAB International; 2011.
12. Yoon SS, Karabulut AC, Lipscomb JD, Hennigan RF, Lymar SV, Groce SL, et al. Two-pronged survival strategy for the major cystic fibrosis pathogen, Pseudomonas aeruginosa, lacking the capacity to degrade nitric oxide during anaerobic respiration. Embo J. 2007; 26(15):3662-72. PMID: 17627281.
13. Trunk K, Benkert B, Quack N, Munch R, Scheer M, Garbe J, et al. Anaerobic adaptation in Pseudomonas aeruginosa: definition of the Anr and Dnr regulons. Environ Microbiol. 2010; 12(6):1719-33. PMID: 20553552. doi: 10.1111/j.1462-2920.2010.02252.x
14. Palmer KL, Aye LM, Whiteley M. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol. 2007; 189(22):8079-87. Epub 2007/09/18. JB.01138-07 [pii] doi: 10.1128/JB.01138-07 PMID: 17873029.
15. Herrera MC, Duque E, Rodriguez-Herva JJ, Fernandez-Escamilla AM, Ramos JL. Identification and characterization of the PhhR regulon in Pseudomonas putida. Environ Microbiol. 2010; 12(6):1427-38. doi: 10.1111/j.1462-2920.2009.02124.x PMID: 20050871.
16. Palmer GC, Palmer KL, Jorth PA, Whiteley M. Characterization of the Pseudomonas aeruginosa transcriptional response to phenylalanine and tyrosine. J Bacteriol. 2010; 192(11):2722-8. PMID: 20304990. doi: 10.1128/JB.00112-10
17. Rodriguez-Rojas A, Mena A, Martin S, Borrell N, Oliver A, Blazquez J. Inactivation of the hmgA gene of Pseudomonas aeruginosa leads to pyomelanin hyperproduction, stress resistance and increased persistence in chronic lung infection. Microbiology. 2009; 155(Pt 4):1050-7. Epub 2009/04/01. 155/4/1050 [pii] doi: 10.1099/mic.0.024745-0 PMID: 19332807.
18. Nosanchuk JD, Casadevall A. The contribution of melanin to microbial pathogenesis. Cell Microbiol. 2003; 5(4):203-23. PMID: 12675679.
19. Lesic B, Rahme LG. Use of the lambda Red recombinase system to rapidly generate mutants in Pseudomonas aeruginosa. BMC Mol Biol. 2008; 9:20. Epub 2008/02/06. 1471-2199-9-20 [pii] doi: 10.1186/1471-2199-9-20 PMID: 18248677.
20. Choi KH, Schweizer HP. An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutants. BMC Microbiol. 2005; 5(1):30. Epub 2005/05/24. 1471-2180-5-30 [pii] doi: 10. 1186/1471-2180-5-30 PMID: 15907219.
21. Armstrong D, Carzino R, Grimwood K. Morbidity and mortality associated with spread of a virulent mucoid Pseudomonas aeruginosa strain in a cohort of cystic fibrosis infants. Pediatric Pulmonology. 1999; 28(Supplement 19):269.
22. Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, Ausubel FM. Common virulence factors for bacterial pathogeneticity in plants and animals. Science. 1995; 268:1899-902. PMID: 7604262
23. Palmer KL, Mashburn LM, Singh PK, Whiteley M. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol. 2005; 187(15):5267-77. Epub 2005/07/21. 187/15/5267-a [pii] doi: 10.1128/JB.187.15.5267-5277.2005 PMID: 16030221.
24. Palmer KL, Brown SA, Whiteley M. Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum. J Bacteriol. 2007; 189(12):4449-55. Epub 2007/04/03. JB.00162-07 [pii] doi: 10.1128/JB.00162-07 PMID: 17400735; PubMed Central PMCID: PMC1913347.
25. Wiehlmann L, Wagner G, Cramer N, Siebert B, Gudowius P, Morales G, et al. Population structure of Pseudomonas aeruginosa. Proc Natl Acad Sci USA. 2007; 104(19):8101-6. PMID: 17468398.
26. Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, Kamani MC, et al. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell. 2002; 3 (4):593-603. PMID: 12408810.
27. Alper S, McBride SJ, Lackford B, Freedman JH, Schwartz DA. Specificity and complexity of the Caenorhabditis elegans innate immune response. Mol Cell Biol. 2007; 27(15):5544-53. PMID: 17526726.
28. Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med. 2011; 17(3-4):293-307. Epub 2010/11/04. molmed.2010.00138 [pii] doi: 10.2119/molmed.2010.00138 PMID: 21046059; PubMed Central PMCID: PMC3060975.
29. Corteling R, Wyss D, Trifilieff A. In vivo models of lung neutrophil activation. Comparison of mice and hamsters. BMC Pharmacol. 2002; 2:1. Epub 2002/01/25. PMID: 11806755; PubMed Central PMCID: PMC64786.
30. Downey DG, Bell SC, Elborn JS. Neutrophils in cystic fibrosis. Thorax. 2009; 64(1):81-8. Epub 2008/12/24. 64/1/81 [pii] doi: 10.1136/thx.2007.082388 PMID: 19103874.